Skip to navigation Skip to content



Congressional leaders re-introduce legislation to address the high cost of prescription drugs

April 22, 2021

This week, Congressional leaders from both parties re-introduced legislation from the previous Congress that would address the high cost of prescription drugs. On Wednesday, April 21, Republican leaders introduced the Lower Costs, More Cure Act (H.R. 19) and on Thursday, April 22, Democratic leaders introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).  

The Society is glad that Congressional leaders are turning their attention to addressing the high cost of prescription drugs and will be evaluating these proposals to ensure they take meaningful actions to lower the cost of medications for people with MS. We look forward to working with Congressional leaders from both parties and urge Congress to pass comprehensive legislation to address the high cost of medications so that people have access to the therapies they need to live their best lives.  

Learn more about the National MS Society’s access to MS medications recommendations, latest survey data, and to hear the stories of people affected by access to MS medications. 

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.